Antisense oligonucleotides for therapeutic intervention
暂无分享,去创建一个
[1] B. Calabretta,et al. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. , 1991, Science.
[2] E. Kieff,et al. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.
[3] Gwyn T. Williams. Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.
[4] S. Swerdlow,et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.
[5] C. Sartorius,et al. Hybridization arrest of cell-free translation of the malarial dihydrofolate reductase/thymidylate synthase mRNA by anti-sense oligodeoxyribonucleotides. , 1991, Nucleic acids research.
[6] J. Roth,et al. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. , 1991, Cancer research.
[7] B. Calabretta,et al. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] G. Tortora,et al. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] B. Lebleu,et al. Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene. , 1991, Nucleic acids research.
[10] R. Morrison. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. , 1991, The Journal of biological chemistry.
[11] J. Laurence,et al. Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element , 1991, Journal of virology.
[12] E. Wickstrom,et al. Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5' cap region. , 1991, Oncogene research.
[13] G. Tortora,et al. Suppression of malignancy targeting the intracellular signal transducing proteins of cAMP: the use of site-selective cAMP analogs, antisense strategy, and gene transfer. , 1991, Life sciences.
[14] R. Erickson,et al. Antisense inhibition of beta-glucuronidase expression in preimplantation mouse embryos: a comparison of transgenes and oligodeoxynucleotides. , 1991, Antisense research and development.
[15] L. Sheffield. Oligonucleotides antisense to catalytic subunit of cyclic AMP-dependent protein kinase inhibit mouse mammary epithelial cell DNA synthesis. , 1991, Experimental cell research.
[16] S. L. Berger,et al. Prothymosin alpha antisense oligomers inhibit myeloma cell division. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[17] F. Szoka,et al. Rapid nuclear accumulation of injected oligodeoxyribonucleotides. , 1990, The New biologist.
[18] T. Lee,et al. Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication , 1990, Molecular and cellular biology.
[19] R. Schultz,et al. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. , 1990, Cancer research.
[20] K. Watabe,et al. Antisense oligodeoxyribonucleotides inhibit the expression of the gene for hepatitis B virus surface antigen. , 1990, The Journal of general virology.
[21] Y. Cheng,et al. Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine. , 1990, The Journal of biological chemistry.
[22] G. Nabel,et al. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. , 1990, Science.
[23] F. Ruscetti,et al. Inhibition of murine monocyte proliferation by a colony-stimulating factor-1 antisense oligodeoxynucleotide. Evidence for autocrine regulation. , 1990, Journal of immunology.
[24] B. Calabretta,et al. Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients. , 1990, Cancer research.
[25] Y. Cho‐Chung. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. , 1990, Cancer research.
[26] J. Toulmé,et al. Blockage of AM V reverse transcriptase by antisense oligodeoxynucleotides , 1990, FEBS letters.
[27] Eli Gilboa,et al. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication , 1990, Cell.
[28] J C Reed,et al. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. , 1990, Cancer research.
[29] H. Buck,et al. Inhibition of HIV-1 infectivity by phosphate-methylated DNA: retraction. , 1990, Science.
[30] L. Neckers,et al. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line. , 1990, Cancer research.
[31] L. Leserman,et al. Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region. , 1990, The Journal of biological chemistry.
[32] A. Rhodes,et al. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. , 1990, The Journal of general virology.
[33] J. Toulmé,et al. Effect of RNA secondary structure and modified bases on the inhibition of trypanosomatid protein synthesis in cell free extracts by antisense oligodeoxynucleotides. , 1990, Nucleic acids research.
[34] B. Calabretta,et al. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[35] James C. Marsters,et al. Synthesis, hybridization properties and antiviral activity of lipid- oligodeoxynucleotide conjugates , 1990, Nucleic Acids Res..
[36] J. Toulmé,et al. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. , 1990, Biochimica et biophysica acta.
[37] Y. Cheng,et al. Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides , 1990, Antimicrobial Agents and Chemotherapy.
[38] P. Nowell,et al. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[39] H. Buck,et al. Phosphate-methylated DNA aimed at HIV-1 RNA loops and integrated DNA inhibits viral infectivity. , 1990, Science.
[40] B. Shiramizu,et al. Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide , 1990, The Lancet.
[41] J. Rossi,et al. Ribozymes as potential anti-HIV-1 therapeutic agents. , 1990, Science.
[42] C. Boiziau,et al. Les oligonucléotides antisens : outils de génétique moléculaire et agents thérapeutiques , 1990 .
[43] E. Wickstrom,et al. Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells. , 1990, Oncogene research.
[44] G. Tortora,et al. An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[45] S. V. Vinogradov,et al. A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus‐specific proteins in MDCK cells , 1990, FEBS letters.
[46] M. Kirschner,et al. An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes , 1989, Cell.
[47] W. Knöchel,et al. An antisense transcript from the Xenopus laevis bFGF gene coding for an evolutionarily conserved 24 kd protein. , 1989, The EMBO journal.
[48] B. Rayner,et al. α-DNA IX: parallel annealing of α-anomeric oligodeoxyribonucleotides to natural mRNA is required for interference in RNase H mediated hydrolysis and reverse transcription , 1989 .
[49] S. Broder,et al. Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. , 1989, Biochemistry.
[50] E. Gilboa,et al. Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA , 1989, Journal of virology.
[51] R. Simons,et al. Naturally occurring antisense RNA control--a brief review. , 1988, Gene.
[52] M. Reitz,et al. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Toulmé,et al. An acridine-linked oligodeoxynucleotide targeted to the common 5' end of trypanosome mRNAs kills cultured parasites. , 1987, Gene.
[54] H. Weintraub,et al. Inhibition of thymidine kinase gene expression by anti-sense RNA: A molecular approach to genetic analysis , 1984, Cell.
[55] M. Stephenson,et al. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. , 1978, Proceedings of the National Academy of Sciences of the United States of America.